TQH2722
- Generic Name
- TQH2722
Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis
Phase 2
Recruiting
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: TQH2722 Placebo
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- Target Recruit Count
- 168
- Registration Number
- NCT06760182
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Peking University Third Hospital, Beijing, Beijing, China
To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
Phase 3
Not yet recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Placebo of TQH2722 injection
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT06552520
- Locations
- 🇨🇳
Chengdu Second People's Hospital, Chengdu, Sichuan, China
🇨🇳The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
🇨🇳The Second Affiliated Hospital of Xiamen Medical College, Xiamen, Fujian, China
A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
Phase 1
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Placebo to match TQH2722
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT05409326
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath